Dapagliflozin - HY-10450
Nur noch %1 verfügbar
Catalog #
HY-10450
Ab
52,00 €
Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine[1]. Dapagliflozin induces HIF1 expression and attenuates renal IR injury[2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-10450/Dapagliflozin-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Metabolism-sugar/lipid metabolism |
| Alternative Names | BMS-512148 |
| CAS | 461432-26-8 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 408.87 |
| Solubility | DMSO : 140 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | SGLT |
| Application: | Metabolism-sugar/lipid metabolism |
|---|